14. Kanyama, M. et al.: Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular
joint osteoarthritis. J. Orofac. Pain 14:20-30; 2000.
15. Volk, S.W. et al.: Gelatinase activity in synovial fluid and synovium obtained from healthy and osteoarthritic joints of dogs. AJVR 64:1225-1233; 2003.
16. Clegg, P.D.; Carter, S.D.: Matrix metalloproteinase-2 and -9 are activated in joint diseases. Equine Vet. J. 31:324-330; 1999.
17. Coughlan, A.R. et al.: Matrix metalloproteinases 2 and 9 in canine rheumatoid arthritis. Vet. Rec. 143:219-223; 1998.
18. Curtis, C.L. et al.: Pathologic indicators of degradation and inflammation in human osteoarthritic cartilage are abrogated by exposure to n-3
fatty acids. Arthritis Rheum. 46:1544-1553; 2002.
19. Masuhara, K. et al.: Matrix metalloproteinases in patients with osteoarthritis of the hip. Int. Orthop. 24:92-96; 2000.
20. Masuhara, K. et al.: Significant increases in serum and plasma concentrations of matrix metalloproteinases 3 and 9 in patients with rapidly
destructive osteoarthritis of the hip. Arthritis Rheum. 46:2625-2631; 2002.
21. Panula, H.E. et al.: Elevated levels of synovial fluid PLA2, stromelysin (MMP-3) and TIMP in early osteoarthrosis after tibial valgus osteotomy in young beagle dogs. Acta. Orthop. Scand. 69:152-158; 1998.
22. Tanaka, A. et al.: Expression of matrix metalloproteinase-2 and -9 in synovial fluid of the temporomandibular joint accompanied by anterior
disc displacement. J. Oral. Pathol. Med. 30:59-64; 2001.
23. McCoy, J.M. et al.: The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis. J. Clin. Invest. 110:651-658; 2002.
24. Martel-Pelletier, J. et al.; Cyclooxygenase-2 and prostaglandins in articular tissues. Semin. Arthritis Rheum. 33:155-167; 2003.
25. Dvorak, L.D. et al.: Effects of carprofen and dexamethasone on canine chondrocytes in a three-dimensional culture model of osteoarthritis. AJVR 63:1363-1369; 2002.
26. Pan, M.R. et al.; Non-steroidal anti-inflammatory drugs inhibit matrix metalloproteinase-2 expression via repression of transcription in
lung cancer cells. FEBS Letters
508:365-368; 2001.
27. Mathews, M.B.; Lozaityte, I.: Sodium chondroitin sulfate-protein complexes of cartilage. I. Molecular weight and shape.
Arch. Biochem. Biophys. 74:158-174; 1958.
28. Aigner, T. et al.: Roles of chondrocytes in the pathogenesis of osteoarthritis. Current Opinion Rheumatol.
4:578-584; 2002.
29. Goldring, M.B.; Berenbaum F.: Human chondrocyte culture models for studying cycolooxygenase expression and prostaglandin
regulation of collagen gene expression. Osteoarthritis Cartilage 7:386-388; 1999.
30. Lotz. M.: The role of nitric oxide in articular cartilage damage. Rheum. Dis. Clin. North Am. 25:269-282; 1999.
|
Featuring Information from:
